The Centers for Medicare and Medicaid Services published a proposed rule on November 20 that would change the policy and technical requirements for Medicare Advantage, the Medicare prescription drug benefit, Medicare cost plans, and the Programs of All-Inclusive Care for the Elderly. The rule, CMS-4214-P2, is the agency's second proposed rule for contract year 2028.

The proposal covers a lot of ground. It would require plans to adopt a standardized electronic prior authorization interface, define when a network change is significant enough to trigger notices and special enrollment periods, overhaul the rules for agent and broker compensation, implement the drug price negotiation data requirements, cap cost sharing for emergency and ambulance services, and change how plans request enrollment capacity.

The program context

Medicare Advantage is the private-plan alternative to Original Medicare, and it covers about half of eligible beneficiaries. Plans receive a risk-adjusted payment from the government and provide the Medicare benefit, often with extra benefits such as dental, vision, and fitness.

The program has grown quickly, and so has the scrutiny. Prior authorization, network adequacy, marketing practices, and risk-adjustment coding have all been subjects of oversight hearings and reports. The proposed rule is the agency's latest attempt to tighten the rules without changing the underlying structure.

Part D is the prescription drug benefit, delivered through standalone plans or through Medicare Advantage prescription drug plans. The rule's Part D provisions are mostly technical, and they interact with the drug price negotiation program.

Prior authorization

The rule would require Medicare Advantage plans to include a contract term requiring in-network providers to submit prior authorization requests and supporting documentation through the plan's FHIR-based Prior Authorization API. Plans would also have to test annually whether their in-network providers can exchange information through the API.

The goal is to replace faxes, portals, and phone calls with a standard electronic exchange. A plan that can receive a request and return a decision through an API can process it faster, and a provider that can submit through the API can avoid duplicate paperwork.

The proposal also asks for information on how the requirement would affect rural providers and the broader health technology ecosystem. That request suggests the agency knows the mandate could be difficult for small practices and for providers with limited technology budgets.

Provider terminations and continuity

The rule would define a "significant change" to a plan's network as one that affects at least 10 percent of the plan's enrollees or at least 10 percent of the contracted network in a specialty. When a change is significant, the plan would have to notify enrollees once the change is final and tell them about their special enrollment period rights.

Plans would also have to continue covering a terminated provider at in-network rates and cost sharing for at least 90 days. The continuity requirement is meant to protect enrollees who are mid-treatment when a contract ends.

The proposal would align the definition of an affected enrollee with a consistent one-year lookback and consolidate the termination and special enrollment notices. Those changes are procedural, and they determine whether an enrollee learns about a network change in time to act.

Agent and broker compensation

The proposal would remove the CMS-defined compensation caps, renewal limits, and referral fee caps for agents and brokers. It would replace them with what the agency describes as market-based guardrails, an outlier-identification method with payment restrictions, and improved data collection.

The rule would also reduce duplicative reporting and training, revise the definitions, and allow mid-year compensation changes with advance notice to CMS. The changes are a significant shift in how the agency oversees the marketing channel for Medicare Advantage and Part D plans, Becker's Payer Issues noted.

Agents and brokers are the main way many beneficiaries choose a plan. The compensation rules shape which plans get marketed and how much time an agent spends with a beneficiary. The proposal would give the market more room and the agency more data.

Maximum fair price

The rule would add a contract requirement for the maximum fair price provisions of the drug price negotiation program. Network provider contracts would have to require providers to enroll in the Medicare Transaction Facilitator Data Module when they furnish selected Part B negotiated drugs.

Plans would have to submit related encounter records within 30 days of the claim date, include 11-digit National Drug Code data, and calculate out-of-network cost sharing using a price no higher than the maximum fair price. The provisions are technical and they matter for the drugs selected for negotiation.

Emergency and ambulance costs

The proposal would set limits on cost sharing for emergency services at $180 to $240, depending on the plan's maximum out-of-pocket limit. Ground ambulance coinsurance would be capped at 30 to 50 percent of Medicare's average cost, or $180 to $300 by maximum out-of-pocket limit.

CMS would update the amounts annually using projections from its Office of the Actuary. The caps are meant to protect enrollees from large bills for emergency care and ambulance transport, which are services that patients do not choose in advance.

Enrollment capacity

The rule would evaluate requests to limit enrollment during the bid submission process and rescind the separate out-of-bid request process. It would create a special enrollment period for enrollees who choose a plan that has reached its capacity limit.

The changes are administrative. They determine how a plan can limit its enrollment and how an enrollee can move if a plan is full. The agency is trying to make the process more predictable for both sides.

The Star Ratings change

The proposal would set a 15-measure Star Ratings set for the 2028 measurement period and the 2030 ratings year. Star Ratings determine quality bonuses and are published for beneficiaries to compare plans.

Changing the measure set changes which plans are rewarded and which are penalized. A plan that performs well on a measure that is removed loses an advantage; a plan that performs poorly on a measure that is added has a new problem.

The agency has been revising the Star Ratings for several years, and the proposal continues that process. The details of the 15 measures will matter to plans and to the consultants who help them improve their scores.

The ADVaNCE model

The rule would make the ADVaNCE Medicare Advantage model mandatory for 10 years starting in 2029, with pre-implementation beginning June 8, 2027. The model is a value-based care initiative, and making it mandatory is a significant change from the voluntary model approach the agency has generally used.

A mandatory model gives the agency more data and more leverage over plan behavior. It also gives plans less ability to opt out, which is why mandatory models are often controversial.

The pre-implementation date gives plans a year and a half to prepare. The details of the model will determine how much work that is.

Other provisions

The proposal would create a standardized definition of "healthy food" for supplemental benefits, Mintz summarized, which plans can offer as an extra. It would make the ADVaNCE Medicare Advantage model mandatory for 10 years starting in 2029, with pre-implementation beginning June 8, 2027. It would set a 15-measure Star Ratings set for the 2028 measurement period and the 2030 ratings year.

It also includes changes for special needs plans and burden-reduction measures, including the sunset of compound-drug balance-billing protection on January 1, 2028.

The drug negotiation context

The maximum fair price provisions implement the drug price negotiation program created by the Inflation Reduction Act. The program allows the government to negotiate prices for selected drugs, and the maximum fair price is the ceiling for the negotiated price.

The rule's requirements are about data. Plans have to submit encounter records, use the 11-digit National Drug Code, and calculate out-of-network cost sharing using a price no higher than the maximum fair price. The provisions make the negotiated price operational at the plan level.

The drug negotiation program has been contested in court and in Congress. The rule does not change the statute; it implements the data and contracting requirements that the program needs to function.

What plans should do

The first step is an inventory of the affected systems. The prior authorization API, the encounter data feed, the compensation reporting, and the cost-sharing calculations are separate projects with separate owners.

The second step is the calendar. The rule is a proposal, and the final rule will set the compliance dates. A plan that waits for the final rule may have less time than it needs.

The third step is the comment process. A plan that sees a provision it cannot implement should say so, with specifics, through the Federal Register docket. The comments are the agency's main source of information about operational feasibility, and the comment file will be public, which means a plan's concerns become part of the record either way.

What it means

For plans, the rule is a set of operational projects: a new API, new termination notices, a new compensation framework, new encounter data, and new cost-sharing calculations. Each has a deadline and a compliance cost.

For providers, the API mandate and the network-continuity requirement are the most direct changes. A practice that submits prior authorizations by fax would need a new workflow, and a provider whose contract ends would have a 90-day runway at in-network rates.

For enrollees, the effects are indirect but real. The network-change notices, the continuity requirement, and the ambulance caps are protections that show up when something goes wrong. The compensation changes affect the advice they get when they choose a plan.

The rule is a proposal. CMS will take comments through the Federal Register docket, and the final rule will likely change some of the provisions. The direction, toward more standardized data and more enrollee protection, is clear. The final rule will show how far the agency is willing to go, and the plans will show how quickly they can comply. The proposal will be judged by whether the provisions work in practice, not by the sheer length of the agency's fact sheet for plans.

Primary sources

  1. CMS fact sheet on the Contract Year 2028 policy and technical changes, CMS-4214-P2, for the provisions and the publication date.
  2. Federal Register document 2026-23960, for the regulatory text and the comment process.
  3. Becker's Payer Issues, for the summary of the provider directory and PBM provisions in the earlier CAA rule.
  4. Mintz, for the analysis of the CAA Medicare provisions and their relationship to this rule.